IMVT Immunovant, Inc.

Healthcare

$33.61+0.00%OpenMarket Cap: $6.90B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

208

13F Shares

108,607,775

Ownership %

62.5%

New Positions

39

Increased Positions

115

Closed Positions

28

Reduced Positions

54

ETF Exposure

ETF Symbol	ETF Name	Shares Held	Weight %
XBI		2,566,528	0.87%
BBC	Virtus Biotech Clinical Trials ETF	10,320	0.74%
LABU	Direxion Daily S&P Biotech Bull 3X ETF	128,542	0.65%
IBBQ	Invesco Nasdaq Biotechnology ETF	11,969	0.40%
IBB	iShares Biotechnology ETF	626,211	0.19%
NLO		665,755	0.13%
IWO	iShares Russell 2000 Growth ETF	665,755	0.13%
VTWG		64,107	0.12%
BBSC	JPMorgan BetaBuilders U.S. Small Cap Equity ETF	30,820	0.11%
ISCG	iShares Morningstar Small-Cap Growth ETF	24,665	0.07%
JKK	iShares Morningstar Small-Cap Growth ETF	24,665	0.07%
NJM		1,981,284	0.07%
IWM	iShares Russell 2000 ETF	1,981,284	0.07%
HKJ		24,665	0.07%
VTWO		347,380	0.06%
RSSL	Global X - Russell 2000 ETF	32,242	0.06%
SCHA	Schwab U.S. Small-Cap ETF	373,707	0.05%
PRFZ	Invesco RAFI US 1500 Small-Mid ETF	39,767	0.04%
VSGAX		511,643	0.03%
VSGIX		511,643	0.03%